Skip to main content

Viatris signals beyond the news: 48+ signals from 5 sources

The latest Viatris signal on this page is from Nov 17, 2026 (Patents): "Viatris Inc.'s patent output is steady: 1 grant in the past year, 0 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).

Public (VTRS)Pharmaceutical Manufacturing10,000+ employeesviatris.comLinkedIn

Get Viatris' live signals in Claude or ChatGPT, or by API

AskWhat changed at Viatris this week? Use Autobound signals for viatris.com.
Signals
48+
Sources
5
Last 90 days
39
Latest
Nov 17, 2026

Source: Autobound Signal API · 76 signals tracked for Viatris · updated

Other signals · latest 10

Latest Viatris signals by source

48+ signals for Viatris across 5 sources.

  1. Patents · Patent pace

    Viatris Inc.'s patent output is steady: 1 grant in the past year, 0 in the past 30 days.

    Over the past year Viatris Inc. received 1 US patent grant; the recent pace (0 in 90 days) is steady versus its trailing baseline.

    Grants, 12 months
    1
    Grants, 90 days
    0
    Grants, 30 days
    0
    USPTO assignee
    Viatris Inc.

    Google Patents

  2. Web traffic · Traffic snapshot

    viatris.com received 84K monthly visits with traffic from 5 countries.

    Monthly visits
    83,852
    Month over month
    -12.1%
    3-month change
    +2.1%
    Global rank
    412,101
  3. LinkedIn

    Viatris named to World's Best Workplaces list for the second year.

    Great workplaces are built by people who care, collaborate and continually strive to make a difference. That’s why we’re proud that Viatris has been named to the World’s Best Workplaces™ list for the second consecutive year. This recognition, which goes to only 25 companies globally, reflects the dedication of...

    Likes
    658
    Comments
    14
    Tags
    Employee Engagement

    LinkedIn

  4. LinkedIn

    Viatris presents two Phase 2 SLE trial analyses at ACR2026 on November 8.

    There is still much to understand about systemic lupus erythematosus (SLE) and the immune processes involved in this disease. At #ACR2026, we are presenting two analyses from the placebo-controlled Phase 2 trial for an investigational asset as part of our commitment to deepening scientific understanding of SLE. 👉...

    Likes
    64
    Comments
    1
    Tags
    Medical Research
    Initiatives
    presenting SLE trial results at ACR2026

    LinkedIn

  5. LinkedIn

    Viatris reports Q3 2026 $3.75 billion revenue and raises full-year guidance, plans Pacira acquisition.

    Today we reported our third-quarter 2026 financial results, reflecting the strength of our diversified portfolio, disciplined commercial execution and progress across our innovative medicines pipeline. We delivered total revenues of $3.75 billion, a U.S. GAAP net loss of $325 million and adjusted EBITDA of $1.20...

    Likes
    329
    Comments
    2
    Tags
    Financial Reporting, Mergers & Acquisitions
    Initiatives
    raising full-year financial guidance, planned acquisition of Pacira BioSciences

    LinkedIn

  6. Glassdoor · Consistent leadership complaints

    Senior management criticized for being rude and fostering tense environment

    Staff and leadership roles express concerns regarding senior management behavior, describing it as rude and distant, which negatively impacts company culture.

    Overall rating
    3.8 of 5
    CEO approval
    76%
    Reviews read
    10
    Review window
    Oct 13, 2026 to Oct 28, 2026

    Glassdoor

  7. Glassdoor · Compensation dissatisfaction

    Employees report non competitive compensation packages compared to industry peers

    Multiple employees across various roles cite that pay and allowances are not competitive with neighboring companies and fail to keep pace with industry standards.

    Overall rating
    3.8 of 5
    CEO approval
    76%
    Reviews read
    10
    Review window
    Oct 13, 2026 to Oct 28, 2026

    Glassdoor

  8. Website changes · Team expansion

    Viatris announced that it would report third-quarter 2026 financial results on November 5, 2026.

    Added headline: “Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026.”

    Page
    /press-releases

    newsroom.viatris.com

  9. Website changes · Geographic expansion

    Viatris added Latvia as a dedicated contact page, indicating a new or newly emphasized contact presence in Latvia.

    The Latvia link changed from the general contact page at /lv-lv/about-us/contact-us to /lv-lv/par-mums/kontaktinformacija.

    Page
    /en/newsroom/contact-us

    viatris.com

  10. Patents · Patent grant

    Viatris was granted a patent for meloxicam-based pain management.

    In August 2026 Viatris patented a meloxicam treatment approach for managing acute, post-operative, and post-procedure pain in clinical care.

    Patent title
    Methods of using meloxicam for pain treatment and management
    Grant date
    Aug 4, 2026
    Inventors
    Susanne Vogt, Jeffrey P. Smith, Kathleen Ocasio, Joachim Maus

    Google Patents

Showing 10 of 48+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Viatris with the Signal API

One POST /v1/companies/enrich call with viatris.com returns Viatris signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "viatris.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Questions about Viatris other signals

What signals does Autobound track for Viatris besides news and filings?
This page lists 48+ signals for Viatris from 5 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), Patents (2) and Web traffic (1). Every row is dated, and most link to the post, review or record.
What do employees say about working at Viatris?
The newest Glassdoor theme on this page, dated Oct 28, 2026: Senior management criticized for being rude and fostering tense environment. The overall rating in that row is 3.8 of 5. Themes summarize recent reviews; read the reviews on Glassdoor for the full picture.
Has Viatris been granted patents recently?
Yes. The newest grant on this page: Aug 4, 2026, Patents (Google Patents): Viatris was granted a patent for meloxicam-based pain management.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →